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Volume 51, Number 4 Abstracts 1065with delayed abdominal closure died before discharge from the hospital
(four in the ruptured AAA group and one in the mesenteric revascularization
group). No deaths were associated with clinical graft infection. In the 18
survivors, 16 were treated for ruptured AAAs. Mean follow-up of the
surviving patients was 53  24.2 months. Two patients died of cardiac
causes at 13 and 34 months, and the remaining 16 were alive at the time data
were collected for this report. No surviving patients have had clinical signs or
symptoms of graft infection.
Comment: Abdominal compartment syndrome is now recognized as a
contributor to mortality in patients treated for ruptured AAA. Early con-
cerns about late graft infection in patients treated with open abdomens
and newly implanted prosthetic grafts appear to be unfounded. Longer
follow-up from multiple centers will be required to truly delineate the risk of
late graft infection in patients managed with an open abdominal wound after
implantation of an abdominal prosthetic graft. However, accumulating
evidence in the short- and intermediate-term suggests the benefits of
vacuum-packed temporary wound closure are real, and prosthetic graft
infections very infrequent.
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Conclusion:Only 20% of identified patients with symptomatic internal
carotid artery (ICA) stenosis in the United Kingdom (UK) have surgery
within the 2-week target timeline set by the National Institute for Health
and Clinical Excellence (NICE).
Summary:Carotid endarterectomy (CEA) reduces the risk of stroke in
patients with 50% to 99% ICA stenosis producing symptoms. Most benefit
occurs when patients are operated on within the first 2 weeks of the onset ofsymptoms (Lancet 2004;363:915-24). The authors note that delays to
surgery have been reduced substantially in some centers in the UK (Lancet
2007;370:1432-42) but that overall performance in performing prompt
CEA after symptoms is unknown. About 4500 CEAs are performed each
year in the UK. The authors sought to identify the proportion of CEAs
performed for symptomatic disease and the time from presentation of
symptoms to performance of CEA in the UK.
The authors sought information from UK surgeons performing CEA
between December 2005 and December 2007, and 240 consultant sur-
geons (61% of those eligible) from 102 hospitals (76%) took part. National
hospital episodes statistics recorded 9913 CEAs, and 5513 were included in
this study. Of the patients undergoing CEA, 83% had a history of transient
ischemic attack or stroke. Of the patients who had symptoms, 20% had their
operation 2 weeks of symptom onset, and 30% waited 12 weeks. Hos-
pital operative mortality was 0.5%, and 30-day mortality was 1.0%.
Comment: The Department of Health in the UK recommends CEA
be done48 hours of symptoms in patients with transient ischemic attack or
minor stroke who are neurologically stable (Department of Health, National
Stroke Strategy 2007; www.dh.gov.uk/publications). Recommendations
and actual clinical practice appear discordant. The article indicates that there
are delays in the performance of CEA for symptomatic patients but does not
indicate the reasons for delay or if additional events occurred while the
patients waited for their operation. A similar study from Canada (Stroke
2009;40:2776-82) that used data from 12 stoke centers in Ontario showed
only about one-third of the patients underwent CEA within the recom-
mended 2-week target time frame. In 25% surgery was delayed 3 months.
American surgeons should note that almost all patients undergoing
CEA in the UK do so for symptomatic disease. In some states in the United
States, 90% of CEAs are performed for asymptomatic disease. Carotid
stenosis is either being vastly over-treated or vastly under-treated on the
opposite sides of the Atlantic.
